Ads
related to: sava stock price forecast 30 days
Search results
Results From The WOW.Com Content Network
As I discussed in my last article on Cassava Sciences (NASDAQ:SAVA), controversy continues to weigh on the performance of SAVA stock. Over the past week, shares in the clinical-stage biotech firm ...
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022. Source: Pavel Kapysh / Shutterstock.com I ...
Cassava Sciences (NASDAQ:SAVA) stands to gain a good deal this year. This will all depend on the company’s Phase 3 clinical trials progress in the results on actual patients with Alzheimer’s ...
Cassava Sciences, Inc. (SAVA) closed at $47.17 in the latest trading session, marking a -1.34% move from the prior day.
Ultimately, however, for those willing to shoulder the risk, a bet on Cassava at the start of the year has paid off – the stock is up by a huge 900% since 2021 began.
Skip to main content. News